These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8259329)

  • 1. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification.
    Banovac K; Gonzalez F; Wade N; Bowker JJ
    Paraplegia; 1993 Oct; 31(10):660-6. PubMed ID: 8259329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury.
    Spielman G; Gennarelli TA; Rogers CR
    Arch Phys Med Rehabil; 1983 Nov; 64(11):539-42. PubMed ID: 6416224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of etidronate on late development of heterotopic ossification after spinal cord injury.
    Banovac K
    J Spinal Cord Med; 2000; 23(1):40-4. PubMed ID: 10752873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent hypercoagulation associated with heterotopic ossification in patients with spinal cord injury long after injury has occurred.
    Perkash A; Sullivan G; Toth L; Bradleigh LH; Linder SH; Perkash I
    Paraplegia; 1993 Oct; 31(10):653-9. PubMed ID: 8259328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Gonzalez F; Renfree KJ
    J Spinal Cord Med; 1997 Jan; 20(1):60-5. PubMed ID: 9097258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report).
    Stover SL; Hahn HR; Miller JM
    Paraplegia; 1976 Aug; 14(2):146-56. PubMed ID: 823516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin and disodium etidronate for the prevention of recurrence of heterotopic ossification after surgical resection. Two case reports.
    Biering-Sørensen F; Tøndevold E
    Paraplegia; 1993 Aug; 31(8):513-5. PubMed ID: 8414635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rachitic syndrome after disodium etidronate therapy in an adolescent.
    Silverman SL; Hurvitz EA; Nelson VS; Chiodo A
    Arch Phys Med Rehabil; 1994 Jan; 75(1):118-20. PubMed ID: 8291954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of heterotopic ossification in patients with spinal cord injury.
    Banovac K; Gonzalez F
    Spinal Cord; 1997 Mar; 35(3):158-62. PubMed ID: 9076866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors in the appearance of heterotopic ossification in spinal cord injury.
    Bravo-Payno P; Esclarin A; Arzoz T; Arroyo O; Labarta C
    Paraplegia; 1992 Oct; 30(10):740-5. PubMed ID: 1448303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients.
    Garland DE; Alday B; Venos KG; Vogt JC
    Clin Orthop Relat Res; 1983 Jun; (176):197-200. PubMed ID: 6406123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for treating acute heterotopic ossification.
    Haran M; Bhuta T; Lee B
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003321. PubMed ID: 15495048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin?
    Vasileiadis GI; Sakellariou VI; Kelekis A; Galanos A; Soucacos PN; Papagelopoulos PJ; Babis GC
    J Musculoskelet Neuronal Interact; 2010 Jun; 10(2):159-65. PubMed ID: 20516633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WITHDRAWN: Pharmacological interventions for treating acute heterotopic ossification.
    Haran MJ; Bhuta T; Lee BS
    Cochrane Database Syst Rev; 2010 May; 2010(5):CD003321. PubMed ID: 20464723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of eidronate disodium in the prevention of heterotopic ossification in burn patients.
    Shafer DM; Bay C; Caruso DM; Foster KN
    Burns; 2008 May; 34(3):355-60. PubMed ID: 17869001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal cord insults and heterotopic ossification in the pediatric population.
    Garland DE; Shimoyama ST; Lugo C; Barras D; Gilgoff I
    Clin Orthop Relat Res; 1989 Aug; (245):303-10. PubMed ID: 2502349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for heterotopic ossification in spinal cord injury.
    Lal S; Hamilton BB; Heinemann A; Betts HB
    Arch Phys Med Rehabil; 1989 May; 70(5):387-90. PubMed ID: 2497715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP.
    Finerman GA; Stover SL
    Metab Bone Dis Relat Res; 1981; 3(4-5):337-42. PubMed ID: 6820114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of heterotopic ossification after spinal cord injury - clinical outcome after single-dose radiation therapy].
    Citak M; Backhaus M; Kälicke T; Ucher I; Aach M; Meindl R; Muhr G; Frangen TM
    Z Orthop Unfall; 2011 Jan; 149(1):90-3. PubMed ID: 21328187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury.
    Estrores IM; Harrington A; Banovac K
    J Spinal Cord Med; 2004; 27(5):434-7. PubMed ID: 15648796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.